10-Q: Forward Industries Faces Steep Revenue Drop, Raises Capital

Forward Industries reported a significant decline in revenue and increased losses for the quarter, prompting substantial doubt about its ability to continue as a going concern, despite recent capital raises.

Summary

• Revenue from continuing operations decreased by 50.5% to $2.49 million for the three months ended June 30, 2025, compared to $5.04 million in the prior year period.
• Gross profit from continuing operations turned into a loss of $0.62 million for the three months ended June 30, 2025, a significant decline from a profit of $1.31 million in the same period last year.
• Net loss increased to $0.85 million for the three months ended June 30, 2025, up from $0.40 million in the prior year, and to $3.01 million for the nine months ended June 30, 2025, from $1.31 million in the prior year.
• The company reported an accumulated deficit of $22.65 million and working capital of $1.21 million as of June 30, 2025.
• Substantial doubt exists about the company's ability to continue as a going concern for the next 12 months due to forecasted cash flows and declining revenues.
• The company successfully raised approximately $5.66 million in capital between May and August 2025 through Series B Convertible Preferred Stock, an Equity Line of Credit (ELOC), and a registered direct offering.
• The OEM distribution segment was sold in May 2025, and the retail distribution segment was fully discontinued by September 30, 2024, as part of strategic shifts.
• A goodwill impairment charge of $225,000 was recognized in December 2024 due to the loss of a major customer in the design segment.

Sentiment

Score: 2

Explanation: The company faces severe financial distress, including substantial doubt about its going concern ability, significant revenue decline, and increasing losses. While recent capital raises provide temporary liquidity and Nasdaq compliance has been maintained, the underlying business performance is deteriorating, driven by the loss of a major customer and high customer concentration. The outlook remains highly uncertain.

Positives

• Successfully raised approximately $5.66 million in capital through preferred stock, an equity line of credit, and a registered direct offering, improving liquidity.
• Regained compliance with Nasdaq's Stockholders Equity Rule in March 2025, avoiding delisting.
• Implemented cost reduction measures, including two workforce reductions in January and June 2025, to mitigate the impact of declining revenues.
• Completed the sale of the OEM distribution segment, streamlining operations and satisfying outstanding payables to a related party.
• Recognized a gain of $160,223 on the change in fair value of warrant liability.

Negatives

• Experienced a significant 50.5% decrease in revenue from continuing operations for the three months ended June 30, 2025, and a 32.8% decrease for the nine months.
• Gross profit from continuing operations turned into a loss of $0.62 million for the three months ended June 30, 2025, compared to a profit in the prior year.
• Operating loss from continuing operations increased by 457.7% for the three months and 265.4% for the nine months ended June 30, 2025.
• Net loss significantly increased by 112.7% for the three months and 130.3% for the nine months ended June 30, 2025.
• Accumulated deficit grew to $22.65 million as of June 30, 2025.
• Management has identified substantial doubt about the company's ability to continue as a going concern for the next 12 months.
• The loss of a major design customer's insulin patch pump program in December 2024, which represented over 30% of fiscal 2024 consolidated net revenues, is expected to cause a material decrease in future revenues.
• High customer concentration remains a risk, with two customers accounting for 32.4% of consolidated net revenues in the three months ended June 30, 2025, and three customers for 42.5% in the nine months.

Risks

• Substantial doubt about the ability to continue as a going concern due to forecasted cash flows and ongoing losses.
• Inability to expand the customer base or loss of additional customers, particularly given the high concentration of revenue with a few large clients.
• Pricing pressures in the design and engineering services market.
• Failure to enter into purchase agreements for the sale of equity or inability to raise additional capital when needed.
• Inability to maintain compliance with Nasdaq listing standards, despite recent efforts.
• Customers' inability to pay for services, impacting accounts receivable collectability.
• Uncertainty in global markets related to tariffs on imports, which has slowed customer commitments to projects.
• Changes in economic, industry, or market conditions, business operations, or competition could lead to additional goodwill impairment charges.

Future Outlook

Management believes its existing cash balance and working capital may not be sufficient to meet liquidity needs through August 2026, raising substantial doubt about its ability to continue as a going concern. The company expects a material decrease in revenues relative to Fiscal 2024 due to the discontinuation of a major customer's insulin patch pump program. Management plans to raise additional capital through its equity line of credit in the near future, assuming obligations are met, but cannot assure successful sales or beneficial pricing. The company also plans to repay a $600,000 promissory note to Forward China by December 31, 2025, and has committed to additional cash payments of $150,000 each in August and September 2025 related to the OEM segment sale.

Management Comments

• Management initiated cost reduction measures, including two reductions in workforce in January and June of 2025, to mitigate the impact of declining revenues.
• Management continues to evaluate and adjust cost reduction efforts as deemed necessary based on the ongoing needs of the business.
• We cannot provide any assurance that we will be able to continue selling under the ELOC, or if we are able to sell, that we will be able to do so at prices that we believe are beneficial to the Company and its shareholders.
• We plan on repaying the $600,000 promissory note to Forward China on or prior to its maturity date of December 31, 2025.

Industry Context

The company operates as a global design firm serving medical and technology customers, providing hardware and software product design and engineering services. The significant revenue decline is primarily driven by the loss of a major customer's program, highlighting the inherent risk of customer concentration in this specialized service industry. Additionally, global market uncertainties related to tariffs on imports have slowed customer commitments, indicating broader macroeconomic pressures affecting project-based businesses.

Management Changes

Corporate Governance

Legal Proceedings

• No material legal actions or proceedings were ongoing as of June 30, 2025, or through the filing date, that would be material to the company's business.

Related Party Transactions

• The Buying Agency and Supply Agreement with Forward China (owned by former CEO Terence Wise) expired on May 9, 2025, and was subsequently terminated in connection with the sale of the OEM segment.
• The company converted an aggregate of $4,925,000 of amounts due to Forward China into Series A-1 Convertible Preferred Stock through four separate Accounts Payable Conversion Agreements.
• A $600,000 unsecured promissory note payable to Forward China, bearing 8% interest, had its maturity date extended to December 31, 2025.
• The company is obligated to pay Forward China $150,000 each on August 31, 2025, and September 30, 2025, as part of the OEM segment sale agreement.
• The agreement with The Justwise Group Ltd. (owned by former CEO Terence Wise) for design, marketing, and inventory management services related to the Koble brand expired on November 30, 2023.
• No revenues were recognized from a customer whose principal owner is an immediate family member of Jenny P. Yu (Managing Director of Forward China) for the three or nine months ended June 30, 2025.

Stakeholder Impact

• Shareholders face significant dilution from recent and planned equity issuances (Series B, ELOC, direct offering) and potential value erosion due to ongoing losses and going concern doubt.
• Employees have been impacted by workforce reductions in January and June 2025 as part of cost-cutting measures.
• Customers, particularly the largest design customer, have significantly reduced or discontinued programs, impacting the company's revenue base.
• Creditors, specifically Forward China, have seen significant payables converted to preferred stock and debt maturity extended, indicating a restructuring of obligations.

Next Steps

• Repaying the $600,000 promissory note to Forward China on or prior to its maturity date of December 31, 2025.
• Making additional cash payments of $150,000 each to Forward China on August 31, 2025, and September 30, 2025, related to the OEM segment sale.
• Planning to raise additional capital through the Equity Line of Credit (ELOC) in the near future.
• Continuing to evaluate and adjust cost reduction efforts based on business needs.
• Monitoring goodwill for impairment in future periods due to changes in economic, industry, or market conditions.

Key Dates

Recommendation

The company faces severe financial challenges, including substantial doubt about its ability to continue as a going concern, a dramatic decline in revenue, and significant operating and net losses. The loss of a major customer and high customer concentration pose ongoing risks. While recent capital raises provide temporary liquidity, they come with significant shareholder dilution and do not address the fundamental deterioration of the core business. The long-term viability and profitability remain highly questionable, making the stock a high-risk investment with significant downside potential.

Keywords

Forward Industries, SEC Filing, 10-Q, Financial Results, Design Company, Product Design, Engineering Services, Going Concern, Capital Raise, Nasdaq Compliance, Discontinued Operations, Goodwill Impairment, Medical Technology, Hardware Design, Software Design